Latest News
CRO Registration
Genelife® Clinical Research is now CDSCO-registered as a Clinical Research Organization (CRO) in India — Registration No: CRO/MH/2026/000159
Trademark
GENELIFE® is a registered trademark for clinical research and scientific services in India.
Award
Genelife® received the Top Healthcare Leaders Global Award from World Health and Wellness Congress & Awards.
COVID-19 Recognition
Genelife® selected among Dynamic Companies in Healthcare during COVID-19 — demonstrating resilience and continued clinical trial operations through the pandemic.
Clinical Research Blog
Post-Marketing Surveillance for Biosimilars: Why Approval Is Just the Beginning
Biosimilar Regulation in India: Evolving Landscape and Current Perspectives
Clinical Project Management: End-to-End Clinical Trials, RWE & Market Research
Clinical Data Management in Clinical Trials: Importance and Process
Patient Recruitment Challenges in Clinical Trials and How to Overcome Them
Real World Evidence (RWE) in Clinical Research: Importance and Applications
What is Pharmacovigilance and Why It Matters in Clinical Trials
CDSCO Approval Process for Clinical Trials in India: Complete Guide
How to Choose a CRO in India: Key Factors to Consider
Innovations Shaping the Future of Clinical Trials: Genelife Perspective
Phases of Clinical Trials Explained: Phase I–IV in Drug Development
Clinical Trial Process in India: Step-by-Step Guide
What is a CRO? Role of Clinical Research Organizations in India
Regulatory Affairs in Clinical Research: Global Compliance Requirements